20031 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Ear
Methods and compounds to suppress viral genome release and packaging
#302Methods for treating ocular contusion and blunt injury and traumatic injury of the optic nerve
#303Method for the treatment of ear infections
#304Methods and Compositions of P27KIP1 Transcriptional Modulators
#305METHODS AND COMPOSITIONS FOR APPLYING PHARMACOLOGIC AGENTS TO THE EAR
#306Formulations for treatment of hyperthyroidism
#307Use of Hydrolytic and Oxidative Enzymes to Dissolve Biofilm in Ears
#308DISINFECTANT AND ANTIMICROBIAL COMPOSITIONS, IN PARTICULAR FOR THE VETERINARY FIELD
#309Freeze-dried powder of high molecular weight silk fibroin, preparation method therefor and use thereof
#310Foamable otic pharmaceutical compositions
#311Methods of treating ototoxicity
#312Polysaccharide particle mixture
#313Therapeutic agent for ocular fundus disease
#314Compounds that enhance Atoh1 expression
#315PHANTOM PHENOMENA TREATMENT
#316Compositions, systems, and methods for generating inner ear hair cells for treatment of hearing loss
#317Method of identifying a biologically-active composition from a biofilm
#318Method of identifying a biologically-active composition from a biofilm
#319Pharmaceutical composition for preventing or treating sensorineural hearing loss or tinnitus including platelet-rich plasma and method using the same
#320Selective histamine H4 receptor antagonists for the treatment of vestibular disorders
#321ANIMAL TISSUE COLONIZATION AND TREATMENT OF INFECTION
#322Sensorineural hair cell differentiation
#323Treatment using truncated Trk B and Trk C antagonists
#324METHODS FOR THE TREATMENT OF PEDIATRIC OTIC DISORDERS
#325Use of malononitrile compounds for protecting animals from parasites
#326Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders
#327Methods and compounds to suppress viral genome release and packaging
#328LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS
#329Methods of treatment using topical copper ion formulations
#330Controlled-Release CNS Modulating Compositions and Methods for the Treatment of Otic Disorders
#331Methods and compositions for neuroprotection
#332METHOD OF TREATING MIDDLE EAR INFECTIONS
#333THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE
#334METHOD FOR TREATING OTIC INFECTIONS AFTER TYMPANOSTOMY TUBE PLACEMENT
#335METHOD OF TREATING OR PREVENTING INFECTION
#336CONTROLLED RELEASE COMPOSITIONS FOR MODULATING FREE-RADICAL INDUCED DAMAGE AND METHODS OF USE THEREOF
#337GENES OF AN OTITIS MEDIA ISOLATE OF NONTYPEABLE HEAMOPHILUS INFLUENZAE
#338Sterilization of ciprofloxacin composition
#339FINAFLOXACIN SUSPENSION COMPOSITIONS
#340METHOD FOR DETECTION TREATMENT AND PREVENTION OF NEUROLOGICAL DEVELOPMENT DISORDERS
#341Chitosan-based matrices and uses thereof
#342Chitosan-based matrices and uses thereof
#343TREATMENT OF TINNITUS THROUGH MODULATION OF CHLORIDE CO-TRANSPORTER NKCC1 IN THE AUDITORY SYSTEM
#344Aqueous suspension preparation comprising nanoparticles of macrolide antibacterial agent
#345Method and compositions for treatment or prevention of inflammatory conditions
#346Solid drug implants for intracochlear delivery of therapeutics for the treatment of Otic disorders
#347Methods of mammalian retinal stem cell production and applications
#348Method of treating middle ear infections
#349Auris formulations for treating otic diseases and conditions
#350Arylamide compounds and compositions and uses thereof
#351Auris Formulations for Treating Otic Diseases and Conditions
#352Method for preventing nasolacrimal duct obstruction
#353Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
#354Treatment of mammalian physiological reaction of IgE antibodies present in said mammal upon contact with the corresponding antigen
#355CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
#356Method of treatment utilizing an acellular amnion derived therapeutic composition
#357Auris formulations for treating otic diseases and conditions
#358Composition and method for inner ear sensory hair cell regeneration and replacement
#359Foam-forming compositions and methods for delivering an active to a body cavity
#360Powder composition for treating a disorder in the auditory canal of mammals and use thereof
#361Agent for regenerating tympanic membrane or external auditory canal
#362Controlled release antimicrobial compositions and methods for the treatment of otic disorders
#363Islet1 (ISl1) and hearing loss
#364Pharmaceutical compositions for treating ear diseases
#365Transdermal pharmaceutical bases for treating ear disorders
#366Controlled release antimicrobial compositions and methods for the treatment of otic disorders
#367Method of treating disease by auricular anesthesia of cranial nerves
#368Therapeutic use of a growth factor, METRNL
#369CONTROLLED RELEASE ANTIMICROBIAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
#370Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
#371Systems and Methods for Treating Ear Disorders and Formulations Therefor
#372Local cochlear application of statins for stimulating neurite regrowth in the cochlea
#373Topical Copper Ion Treatments and Methods of Treatment Using Topical Copper Ion Treatments in the Oral-Respiratory-Otic Areas of the Body
#374Antimicrobial wash
#375Methods and compositions for treating genetically linked diseases of the eye
#376Sterilization of ciprofloxacin composition
#377Methods of treating topical microbial infections
#378Methods of treating ototoxicity
#379PHARMACOLOGIC TREATMENTS OF MENIÉRE'S DISEASE
#380Foamable otic pharmaceutical compositions
#381Compositions and methods for treating ophthalmic, octic, or nasal infections
#382CONTROLLED RELEASE AURIS SENSORY CELL MODULATOR COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
#383Controlled release corticosteroid compositions and methods for the treatment of otic disorders
#384Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders
#385Aqueous liquid bromfenac composition having preservative efficacy
#386Sterile otic formulations
#387Methods for the treatment of pediatric otic disorders
#388System for treating ear infections
#389Methods for the treatment of tinnitus induced by cochlear excitotoxicity
#390PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INNER EAR DISORDERS
#391Partially absorbable fiber-reinforced composites for controlled drug delivery
#392Treatment of noise induced hearing loss
#393Treating Hearing Loss
#394METHOD OF ADMINISTERING AN INJECTABLE ANTIBIOTIC TO AN ANIMAL
#395Compositions and Methods for Preventing and/or Treating Sensorineural Hearing Loss
#396Compounds that enhance Atoh1 expression
#397Methods for treating ocular contusion and blunt injury and traumatic injury to the optic nerve
#398Controlled release antimicrobial compositions and methods for the treatment of otic disorders
#399TOPICAL OPHTHALMIC, OTIC, AND NASAL COMPOSITIONS OF CIPROFLOXACIN
#400Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
#401Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
#402TOPICAL PHARMACEUTICAL COMPOSITIONS OF ANTIBIOTICS AND STEROIDAL ANTI INFLAMMATORY AGENTS
#403METHODS FOR REPAIR OF EAR CANAL TISSUE DEFECTS
#404Systems and methods for anesthetizing ear tissue
#405Methods for the treatment of tinnitus induced by cochlear excitotoxicity
#406SOLID DRUG IMPLANTS FOR INTRACOCHLEAR DELIVERY OF THERAPEUTICS FOR THE TREATMENT OF OTIC DISORDERS
#407Kit-in-parts for cleaning and treating ears of companion animals
#408Local administration of gallium compositions to treat pain
#409Use of stem cells to generate inner ear cells
#410Small molecule compounds to treat hearing loss
#411Compositions with modulating agents
#412Novel Microbial Pathogen inhibitor
#413Peptides for the Treatment of Hearing
#414Pharmaceutical compositions for the treatment of inner ear disorders
#415Controlled release corticosteroid compositions and methods for the treatment of otic disorders
#416Methods and compositions for applying pharmacologic agents to the ear
#417Method of treating middle ear infections
#418Local administration of gallium compositions to treat pain
#419Method for rehydrating polysaccharide particles
#420Methods for improving muscle and heart function
#421Controlled-release CNS modulating compositions and methods for the treatment of otic disorders
#422Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
#423Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body
#424Wax foamable vehicle and pharmaceutical compositions thereof
#425Controlled release compositions for modulating free-radical induced damage and methods of use thereof
#426Methods and devices for delivery of pharmaceutical agents within orifices of the body
#427Otic composition for companion animals
#428Method for preventing nasolacrimal duct obstruction
#429Drug-delivery accessory for an implantable medical device
#430Finafloxacin suspension compositions
#431System and methods for treating ear disorders
#432Use of transplatin to prevent hearing loss
#433Pharmaceutical compositions with phosphonium antimicrobial agents
#434Compositions and methods for treatment of ear disorders
#435Compositions containing moxifloxacin for treating otic infections
#436Healing composition for topical application
#437Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
#438Methods for treating otic infections
#439Method for preventing nasolacrimal duct obstruction
#440Local administration of gallium compositions to treat pain
#441Bio-functionalized stimulus-responsive dissolvable PEG-hydrogels
#442Antimicrobial compositions and methods
#443Aqueous liquid bromfenac composition having preservative efficacy
#444Compositions and methods of using lamellar bodies for modifying linear biological macromolecules
#445Liquid pharmaceutical composition for the delivery of active ingredients
#446Controlled release antimicrobial compositions and methods for the treatment of otic disorders
#447Composition and method for inner ear sensory hair cell regeneration and replacement
#448Regulated delivery systems for inner ear drug application and uses thereof
#449Otic formulations, methods and devices
#450Method of treating otitis externa using macrocyclic lactone compound
#451Controlled Release Ion Channel Modulator Compositions and Methods for the Treatment of Otic Disorders
#452Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders
#453System and method for delivery of a therapeutic agent to the inner ear
#454Arylamide compounds and compositions and uses thereof
#455Method and formulation for treating dry ear inflammation with cortisone
#456Prevention of and Recovery from Drug-Induced Ototoxicity
#457Modular Drug Delivery System for Minimizing Trauma During and After Insertion of a Cochlear Lead
#458Local administration of gallium compositions to treat pain
#459Beta-carbolines for use in the treatment of hearing loss and vertigo
#460COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR SURFACE ALLERGIES
#461Compounds that enhance Atoh1 expression
#462PHANTOM PHENOMENA TREATMENT
#463METHODS AND COMPOSITIONS FOR APPLYING MOXIFLOXACIN TO THE EAR
#464Modulation of Gel Temperature of Poloxamer-Containing Formulations
#465Peptides for the treatment of hearing
#466Methods and compositions for treating diseases, disorders or injury of the CNS
#467Compositions for treatment of ear disorders and methods of use thereof
#468Islet1 (Isl1) and hearing loss
#469SOLID DISPERSION OF RIFAXIMIN
#470Soothing Agents
#471GACYCLIDINE FORMULATIONS
#472Controlled-release CNS modulating compositions and methods for the treatment of otic disorders
#473Local administration of gallium compositions to treat pain
#474COCHLEAR IMPLANT DRUG DELIVERY DEVICE
#475Topical compositions designed to maintain or restore the integrity of the mucous membranes
#476Method for transdermal delivery of permeant substances
#477Methods and devices for delivery of pharmaceutical agents within orifices of the body
#478OTIC FOAM FORMULATIONS
#479Treatment of allergic otitis media in mammals with neurotoxins
#480TOPICAL SOLUTION FORMULATIONS CONTAINING A CORTICOSTEROID AND A CYCLODEXTRIN
#481Composition comprising an antibiotic and a corticosteroid
#482Selective histamine H4 receptor antagonists for the treatment of vestibular disorders
#483OTIC COMPOSITIONS FOR THE TREATMENT OF INFECTIONS OF THE INTERNAL AND EXTERNAL EAR IN MAMMALS
#484Controlled release corticosteroid compositions and methods for the treatment of otic disorders
#485Controlled release corticosteroid compositions and methods for the treatment of otic disorders
#486Controlled release corticosteroid compositions and methods for the treatment of otic disorders
#487Controlled release corticosteroid compositions and methods for the treatment of otic disorders
#488Compositions for treatment of ear disorders and methods of use thereof
#489Drug-delivery accessory for an implantable medical device
#490Composition for the treatment of ear infections and method
#491Methods and compositions for rapid treatment of otitis externa
#492Composition and method of treating hearing loss
#493Topical Use Of Probiotic Bacillus Spores To Prevent Or Control Microbial Infections
#494PHARMACEUTICAL COMPOSITIONS WITH PHOSPHONIUM ANTIMICROBIAL AGENTS
#495Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor
#496REVERSIBLY HEAT-GELABLE AQUEOUS COMPOSITION
#497OPHTHALMIC COMPOSITION
#498Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation
#499INTRACOCHLEAR DRUG DELIVERY TO THE CENTRAL NERVOUS SYSTEM
#500Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
#501Methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
#502Methods comprising serratia peptidase for inhibition of osteomyelitis
#503Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
#504Compositions and methods comprising serratia peptidase for inhibition of bacterial vaginosis, bacterial vaginitis or fungal vaginitis
#505COMPOSITIONS AND METHODS COMPRISING SERRATIA PEPTIDASE FOR INHIBITION AND TREATMENT OF BIOFILMS RELATED TO CERTAIN CONDITIONS
#506Tympanic membrane permeating ear drops and uses thereof
#507Treatment of sinusitis in mammals with clostridia neurotoxins
#508Compositions and methods for treatment of ear disorders
#509METHOD OF IMPROVING WOULD HEALING
#510GACYCLIDINE FORMULATIONS
#511Genes of an otitis media isolate of nontypeable
#512Methods of comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
#513Therapeutic use of a growth factor, METRNL
#514Apparatus and method to generate a mixture of hydrogen peroxide gas and a carrier gas
#515Agent for regenerating tympanic membrane or external auditory canal
#516Method of administering an injectable antibiotic to an animal
#517CHITOSAN-BASED MATRICES AND USES THEREOF
#518Treatment of asthma in mammals with clostridia neurotoxins
#519Treatment of allergic rhinitis in mammals with neurotoxins
#520Treatment of infectious rhinitis in mammals with clostridia neurotoxins
#521Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate
#522Cold ionizing radiation sterilization
#523Phospholipid gel compositions for drug delivery and methods of treating conditions using same
#524Use of transplatin to prevent hearing loss
#525Controlled release corticosteroid compositions and methods for the treatment of otic disorders
#526Methods for treating ophthalmic, otic, or nasal infections
#527METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFECTION OR INFECTIOUS COLONIZATION OF THE EYELID, OCULAR SURFACE, SKIN OR EAR
#528CONCENTRATED AQUEOUS AZALIDE FORMULATIONS
#529Compositions and methods for reducing hepatotoxicity associated with drug administration
#530Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
#531COMPOSITION AND METHOD FOR TREAMENT OF INFLAMATION AND INFECTIONS OF THE OUTER EAR CANAL, NOSE AND PARANASAL SINUSES
#532OPHTHALMIC COMPOSITION
#533Liquid formulations for treatment of diseases or conditions
#534OPHTHALMIC, OTIC OR NASAL PHARMACEUTICAL COMPOSITION AND THE USE THEREOF
#535METHOD AND COMPOSITIONS FOR TREATMENT OR PREVENTION OF INFLAMMATORY CONDITIONS
#536USE OF HYDROLYTIC AND OXIDATIVE ENZYMES TO DISSOLVE BIOFILM IN EARS
#537Systems and methods for anesthetizing ear tissue
#538AQUEOUS COMPOSITION
#539Composition and method to treat otitis media and ventilator- associated pneumonia
#540Pharmaceutical suspension
#541Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
#542Hydrogel-filled drug delivery reservoirs
#543Implantable and Refillable Drug Delivery Reservoir
#544Pharmaceutical composition for meniere's disease
#545COMPOSITION COMPRISING AN ANTIBIOTIC AND A CORTICOSTEROID
#546PHARMACEUTICAL COMPOSITION HAVING RELATIVELY LOW IONIC STRENGTH
#547Method of treating otic infections with moxifloxacin compositions
#548Controlled release antimicrobial compositions and methods for the treatment of otic disorders
#549CELL IMPLANTATION TO PREVENT AND/OR TREAT HEARING LOSS
#550Controlled release compositions for modulating free-radical induced damage and methods of use thereof
#551Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders
#552CONTROLLED RELEASE DELIVERY DEVICES FOR THE TREATMENT OF OTIC DISORDERS
#553CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
#554Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
#555Controlled release ion channel modulator compositions and methods for the treatment of otic disorders
#556Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders
#557CONTROLLED-RELEASE CNS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
#558Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders
#559Auris formulations for treating otic diseases and conditions
#560SELF-PRESERVED EMULSIONS
#561Controlled release immunomodulator compositions and methods for the treatment of otic disorders
#562Modular drug delivery system for minimizing trauma during and after insertion of a cochlear lead
#563Rehydratable polysaccharide particles and sponge
#564THIOLATED CHITOSAN GEL
#565Otic compositions for the treatment of infections of the internal and external ear in mammals
#566Aqueous suspension preparations
#567Pharmaceutical Compositions for the Treatment of Inner Ear Disorders
#568Compositions and methods for reducing hepatotoxicity associated with drug administration and treating non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and associated cirrhosis
#569Methods of inhibiting growth of bacteria, yeast, fungus, and virus with and extracellular products
#570Compounds that enhance Atoh1 expression
#571TOPICAL SOLUTION FORMULATIONS CONTAINING A CORTICOSTEROID AND A CYCLODEXTRIN
#572Pharmaceutical composition for the treatment of otomycosis
#573Topical Use of Probiotic Bacillus Spores to Prevent or Control Microbial Infections
#574Method of treating middle ear infections
#575Composition and method of treating temporary and permanent hearing loss
#576Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate
#577Screening method for compounds that promote differentiation of inner ear progenitor cells
#578Compositions and methods of using lamellar bodies for modifying linear biological macromolecules
#579Concentrated aqueous azalide formulations
#580Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
#581Bridged polycyclic compound based compositions for topical applications for pets
#582Minimizing trauma during and after insertion of a cochlear lead
#583Wax foamable vehicle and pharmaceutical compositions thereof
#584Composition and method for the prevention and relief of the symptoms of an incompetent or patulous Eustachian tube
#585Pharmaceutical for Hygienic Administration in the Ear
#586Methods for Treatment and Prevention of Otitis Media Using Nonionic Surfactants to Facilitate Transmembrane Drug Delivery into the Middle Ear
#587Loteprednol Etabonate Aqueous Suspension
#588Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
#589Methods for Treatment and Prevention of Otitis Media Using Chemical Penetration Enhancers to Facilitate Transmembrane Drug Delivery Into the Middle Ear
#590Use of stem cells to generate inner ear cells
#591Phantom Phenomena Treatment
#592Combination Therapy for Otitis with Antiseptic and pH Adjustment
#593METHOD OF TREATING MIDDLE EAR INFECTIONS
#594Compositions with modulating agents
#595Otologic nanotechnology
#596Treatment of humans with colloidal silver composition
#597Composition for normalizing otitis externa in mammals
#598Methods for Transmembrane Treatment and Prevention of Otitis Media
#599Method for preventing nasolacrimal duct obstruction
#600Local administration of gallium compositions to treat pain